Scarica l'app Stockscreener
10.94
4.54%
-0.52
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Sutro Biopharma Inc Borsa (STRO) Ultime notizie
Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference - Yahoo! Finance Canada
Sutro Biopharma (STRO) Pulls Back 6.85% to $14.27 as Shares Test Key Support ZoneVolume Nodes - https://www.siam.in/
Sutro Biopharma Inc (STRO-Q) Stock Price and News - The Globe and Mail
Sutro Biopharma appoints Lucas Donigian as business head - Investing.com
Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development - Yahoo Finance
An oncology dealmaker with partnerships worth over $2 billion joins Sutro - Stock Titan
Form 4 Sutro Biopharma For: 27 September - Investing.com India
Sutro Biopharma, Inc.(NasdaqGM: STRO) added to S&P Global BMI Index - marketscreener.com
Sutro Biopharma Stock Price Forecast. Should You Buy STRO? - StockInvest.us
Sutro Biopharma (STRO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
A Quick Look at Today's Ratings for Sutro Biopharma(STRO.US), With a Forecast Between $49 to $56 - Moomoo
Mackay Gold & Silver: Mackay Gold & Silver Adds Second Drill Rig to Test the Historic Sutro Tunnel Intersection of the Occidental-Brunswick Lode at Depth, Comstock District, Nevada - FinanzNachrichten.de
Merck & Co. Inc. Invests $9.04 Billion in Sutro Biopharma, Inc. $STRO - MarketBeat
Sutro Biopharma (STRO) Climbs 2.91% as Shares Test Key Resistance at $22.12New Highs New Lows - vinanet.vn
Stifel Maintains Sutro Biopharma(STRO.US) With Buy Rating, Maintains Target Price $48 - Moomoo
Sutro Biopharma (STRO) Shares Slide 3.89% to $20.48 as Selling Pressure IntensifiesDealer Positioning - vinanet.vn
Broker Revenue Forecasts For Sutro Biopharma, Inc. (NASDAQ:STRO) Are Surging Higher - simplywall.st
Earnings Beat: Sutro Biopharma, Inc. (NASDAQ:STRO) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Moomoo
Sutro Biopharma (NasdaqGM:STRO) Stock Forecast & Analyst Predictions - Simply Wall Street
Sutro Biopharma, Inc. (NASDAQ:STRO) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Rating of "Buy" by Analysts - MarketBeat
Sutro Biopharma (STRO): Perceptive Advisors reports 7.9% beneficial stake - Stock Titan
Sutro Biopharma (STRO): Point72 group reports 1.4% stake in 13G/A - Stock Titan
Sutro Biopharma Q3 EPS Forecast Reduced by HC Wainwright - MarketBeat
BofA Securities Maintains Sutro Biopharma(STRO.US) With Sell Rating - Moomoo
STRO Maintained by Citizens -- Price Target Lowered to $34.00 - GuruFocus
Sutro Biopharma (NASDAQ:STRO) Price Target Lowered to $34.00 at Citizens Jmp - MarketBeat
STRO Reiterated by Wedbush -- Price Target Maintained at $60 - GuruFocus
Truist Financial Maintains Sutro Biopharma(STRO.US) With Buy Rating, Announces Target Price $50 - Moomoo
Sutro Biopharma (NASDAQ:STRO) Earns Outperform Rating from Wedbush - MarketBeat
Citizens cuts Sutro Biopharma stock price target on revenue miss - Investing.com
Citizens cuts Sutro Biopharma stock price target on revenue miss By Investing.com - Investing.com Canada
Sutro Biopharma earnings missed by $0.13, revenue fell short of estimates - Investing.com Canada
Is Sutro Biopharma Inc (STRO) Facing Pressures After Q2 Earnings - GuruFocus
Sutro Biopharma Releases Q2 2026 Financial Results - AlphaStreet
Why is Sutro Biopharma Stock Falling On Wednesday? - TradingView
Sutro Biopharma (NASDAQ:STRO) Posts Quarterly Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Sutro Biopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sutro Biopharma Reports Q2 2026 Financial Results and Pipeline Update - Kalkine Media
Sutro Biopharma Announces Q2 2026 Financial Results and Updates Corporate Presentation - Kalkine Media
Form 8K Sutro Biopharma For: 12 August By Investing.com - Investing.com Nigeria
Form 8K Sutro Biopharma For: 12 August By Investing.com - Investing.com South Africa
Sutro Biopharma Q2 Results Highlight Advancing ADC Pipeline - TipRanks
Sutro reports early clinical responses from STRO-004 cancer trial By Investing.com - Investing.com Australia
SUTRO BIOPHARMA, INC. 2Q 2026: Revenue $9.84M, EPS ($2.33) — 10-Q Summary - TradingView
Form 8K Sutro Biopharma For: 12 August By Investing.com - Investing.com Canada
Form 8K Sutro Biopharma For: 12 August By Investing.com - Investing.com India
Form 8K Sutro Biopharma For: 12 August By Investing.com - Investing.com Australia
Sutro Biopharma (STRO) revenue drops as cash rises after $110M stock sale - Stock Titan
Form 8K Sutro Biopharma For: 12 August By Investing.com - Investing.com UK
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):